Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion-Reference-Cited by-同舟云学术

Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion

Published:2000-06 Issue:1-2 Volume:111 Page:115-123
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Jiménez Vasquez Patricia A,Salmi Peter,Ahlenius Sven,Mathé Aleksander A

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference68 articles.

1. Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists;Ault;Schizophr. Res.,1998

2. The effect of neuropeptide Y on striatal catecholamines;Beal;Neurosci. Lett.,1986

3. Effects of antidepressant drug treatment on levels of NPY or prepro-NPY-mRNA in the rat brain;Bellmann;Neurochem. Int.,1993

4. Cerebrospinal fluid neuropeptide Y in depression and schizophrenia;Berrettini;Neuropsychopharmacology,1987

5. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment;Caberlotto;Brain Res. Mol. Brain Res.,1998

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression;Neuroscience & Biobehavioral Reviews;2024-09

2. Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion;Biomedicine & Pharmacotherapy;2023-05

3. GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant‐like effects involving BDNF actions;Journal of Cellular Physiology;2023-01-04

4. A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder;International Journal of Neuropsychopharmacology;2020-10-03

5. Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders;Frontiers in Neuroendocrinology;2019-10